戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 hown to produce lung injury characterized by noncardiogenic pulmonary edema.
2  vascular permeability that leads to severe, noncardiogenic pulmonary edema.
3 be useful in distinguishing cardiogenic from noncardiogenic pulmonary edema.
4 headache, grade 3 hypercalcemia, and grade 3 noncardiogenic pulmonary edema.
5                                 It begins as noncardiogenic pulmonary edema and develops into a neutr
6 nflammatory immune response, capillary leak, noncardiogenic pulmonary edema, and shock in humans.
7                 In healthy marathon runners, noncardiogenic pulmonary edema can be associated with hy
8 ults in damage to the remaining lung tissue, noncardiogenic pulmonary edema, hypoxia, and even death.
9                                              Noncardiogenic pulmonary edema is often associated with
10 ts require hospital admission for pneumonia, noncardiogenic pulmonary edema, or other complications.
11 related acute lung injury (TRALI), a form of noncardiogenic pulmonary edema that develops during or w
12 st, at the bedside, TRALI causes hypoxia and noncardiogenic pulmonary edema, typically within 6 hours
13 atory distress syndrome are characterized by noncardiogenic pulmonary edema, which can be assessed by
14 r epithelial cell (AEC) barrier resulting in noncardiogenic pulmonary edema, which causes acute respi
15 ment, including right ventricular strain and noncardiogenic pulmonary edema, which may potentially al